Purpose of the T-Force Platinum Research Study.

Purpose of the T-Force Platinum Research Study.

The T-Force Platinum Research Study is designed to evaluate the safety and effectiveness of an investigational medication, that is not an antipsychotic medication, in pediatric patients with Tourette syndrome. An investigational medication is one that is not approved by the US Food and Drug Administration (FDA).

Who may qualify.

Who may qualify.

The T-Force Platinum Research Study may be appropriate for those who meet the following criteria:

  • Boys and girls aged 6–17 years
  • Have a diagnosis of Tourette syndrome and symptoms that impair school, occupational, and/or social function
  • Are in good general health, as determined by medical history, physical examination, and laboratory tests

Study schedule.

Study schedule.

Participants in the T-Force Platinum Research Study will need to:

  • Attend a Screening Visit to determine eligibility
  • Participate in the clinical research study for up to 44 weeks, including up to 17 visits at a local study site
  • Receive up to a total of 36 weeks of daily study drug dosing
  • Attend a Follow-Up Visit after completing applicable study visits

Learn more about the T-Force Platinum Research Study.

See If Your Child May Qualify